Search
Now showing items 1-4 of 4
Cardiovascular drug monitoring using quantitative LC-HRMS analysis of self-collected micro-volume blood samples
(2017-09-24)
Background
Evidence suggests that ˃50% of cardiovascular (CVD) disease patients do not adhere to treatment thus impacting on patient health, additional healthcare costs and medicines wastage. DBS microsampling combined ...
LC-HRMS analysis of 133 patient micro-volume blood samples to allow clinical assessment of medication adherence
(The Association for Mass Spectrometry: Applications to the Clinical Lab, 2017-01-25)
133 DBS card/VAMS micro-volume blood samples were analysed by LC-HRMS to determine if therapeutic levels of the prescribed cardiovascular (CVD) drugs were present. This research focussed on the top 11 UK prescribed CVD ...
Quantitative LC-HRMS analysis of dried blood spots to assess adherence to cardiovascular pharmacotherapy
(The Association for Mass Spectrometry: Applications to the Clinical Lab, 2017-01-25)
The analysis of dried blood spot samples (DBS) by liquid chromatography – high resolution mass spectrometry (LC-HRMS) for assessing adherence to candidate cardiovascular therapeutic drugs was investigated. To evaluate the ...
